Back

The predictors of clinical outcome in the patients undergoing endovascular intervention for lower extremity peripheral arterial disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Peripheral angioplasty and complications Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Byung Ok Kim

VHS Medical Center, Seoul (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail
Pathology of balloon angioplasty for below the knee arteries in patients with chronic limb threatening ischemia
Doctor M. Shiozaki (Kanagawa, JP)
Abstract Slides Video
Presentation thumbnail
Clinical impact of endovascular therapy with paclitaxel-based strategy for femoropopliteal lesions in chronic limb-threatening ischaemia
Mr H. Nohara (Sakai, JP)
Abstract Slides Video
Presentation thumbnail
Sirolimus vs paclitaxel for femoropopliteal peripheral artery disease - The limus flow randomized trial
Professor C. Rammos (Essen, DE)
Abstract Slides Video
Presentation thumbnail
Long-term prognosis after bypass surgery versus endovascular therapy in chronic hemodialysis patients with peripheral artery disease -10-year follow-up study
Doctor Y. Kumada (Kasamatsu, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Peripheral angioplasty and complications

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Cardiovascular risk factors in poly-vascular vs isolated lower extremity peripheral arterial disease. analysis from the SOLACI peripheral registry
thumbnail
Congress Presentation
Comparison of long-term prognosis between coronary artery disease and peripheral artery disease in haemodialysis and non-dialysis patients
thumbnail
Congress Presentation
Developing a multi-center registry of peripheral artery disease using natural language processing: unlocking the power of the electronic health record

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources